Enterprise Value
-9.59M
Cash
16.72M
Avg Qtr Burn
-5.432M
Short % of Float
0.49%
Insider Ownership
9.02%
Institutional Own.
29.93%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ALRN-6924 Details Cancer, Small cell lung cancer, Solid tumor/s | Phase 1b Update | |
ALRN-6924 Details Cancer, Breast cancer | Failed Discontinued | |
ALRN-6924 Details Cancer, Non-small cell lung carcinoma | Failed Discontinued |